Literature DB >> 16406242

Current practice in the management of superficial bladder cancer in the Netherlands and Belgian Flanders: a survey.

J A Witjes1, D O T M Melissen, L A L M Kiemeney.   

Abstract

OBJECTIVE: Because there is no national guideline for the diagnosis, therapy and follow up of (superficial) bladder cancer in the Netherlands and Belgium, the actual patient management may differ between urologists. The purpose of this study is to get insight in the current way urologists diagnose, treat and follow patients with superficial bladder cancer.
METHODS: All practising urologists in the Netherlands (n = 293) and Flemish speaking Belgium (Flanders, n = 223) received a questionnaire with regard to the current management of patients with superficial bladder cancer. The results were compared with the guidelines provided by the European Association of Urology (EAU). Also a comparison was made between the two countries and between university and community hospitals.
RESULTS: The results show a wide variation in current practice for superficial bladder cancer. Although the majority of urologists do not follow the EAU guidelines, current practice roughly matches these guidelines. There are no major differences between the two countries or between different types of hospitals. Discrepancies between current practice and guidelines are mostly too frequent use of techniques for the diagnosis, treatment and follow-up.
CONCLUSION: In all, there is a need for clear guidelines in superficial bladder cancer and an effective implementation of such guidelines into everyday practice.

Entities:  

Mesh:

Year:  2005        PMID: 16406242     DOI: 10.1016/j.eururo.2005.11.010

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  5 in total

1.  Genome-wide association study of genetic variations associated with treatment failure after intravesical bacillus Calmette-Guérin therapy for non-muscle invasive bladder cancer.

Authors:  Masaki Shiota; Naohiro Fujimoto; Yoshiaki Yamamoto; Ario Takeuchi; Katsunori Tatsugami; Takeshi Uchiumi; Hideyasu Matsuyama; Masatoshi Eto
Journal:  Cancer Immunol Immunother       Date:  2020-03-02       Impact factor: 6.968

2.  Effect of HLA genotype on intravesical recurrence after bacillus Calmette-Guérin therapy for non-muscle-invasive bladder cancer.

Authors:  Mizuki Kobayashi; Nobuhiro Fujiyama; Tokiyoshi Tanegashima; Shintaro Narita; Yoshiaki Yamamoto; Naohiro Fujimoto; Shohei Ueda; Ario Takeuchi; Kazuyuki Numakura; Tomonori Habuchi; Hideyasu Matsuyama; Masatoshi Eto; Masaki Shiota
Journal:  Cancer Immunol Immunother       Date:  2021-08-11       Impact factor: 6.968

3.  Pattern of management of urologic cancer in Saudi Arabia.

Authors:  Khalid Al-Othman; Naif Al-Hathal
Journal:  Urol Ann       Date:  2010-01

4.  Bladder tissue characterization using probe-based Raman spectroscopy: Evaluation of tissue heterogeneity and influence on the model prediction.

Authors:  Eliana Cordero; Jan Rüger; Dominik Marti; Abdullah S Mondol; Thomas Hasselager; Karin Mogensen; Gregers G Hermann; Jürgen Popp; Iwan W Schie
Journal:  J Biophotonics       Date:  2019-12-02       Impact factor: 3.207

5.  Review of methods and applications of attenuation coefficient measurements with optical coherence tomography.

Authors:  Shuang Chang; Audrey K Bowden
Journal:  J Biomed Opt       Date:  2019-09       Impact factor: 3.170

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.